ImCheck Therapeutics' Series A Round

ImCheck Therapeutics raised a round of funding on May 02, 2017.

ImCheck Therapeutics is a Marseille-based company developing next generation immuno-modulatory antibodies acting on both adaptive and innate immunity (notably gamma-delta T-cells) for the treatment of…

Articles about ImCheck Therapeutics' Series A Round: